Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome | BMC Cancer | Full Text

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome | BMC Cancer | Full Text

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome

Differentiation syndrome (DS) is the main life-threatening adverse event that occurs in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA). Cytokine imbalances have been re...

Authors:Luciana Yamamoto de Almeida, Diego Antonio Pereira-Martins, Ana Sílvia Gouvêa Lima, Márcia Sueli Baggio, Luisa Corrêa de Araujo Koury, Ana Paula Lange, Sarah Cristina Bassi, Priscila Santos Scheucher and Eduardo Magalhães Rego

Citation:BMC Cancer 2020 20:821

Content type:Research article

 

Published on: 28 August 2020

• ViewFull Text
 
• ViewPDF